Schedule 13G ownership disclosure

ORCHARD THERAPEUTICS PLC

Security class unavailable · CUSIP: 68570P101

Event date: 2020-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,364,658
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-045219
Form type
SC 13G/A
Filer
Orchard Therapeutics plc
CIK
CIK 1748907
Filed
Apr 09, 2020
Reporting period
Mar 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub